Free Trial

Harrow (HROW) Competitors

Harrow logo
$39.04 +0.15 (+0.39%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$38.92 -0.12 (-0.31%)
As of 10/23/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HROW vs. LEGN, MTSR, KRYS, PCVX, TGTX, PTCT, ARWR, ACLX, PTGX, and MENS

Should you be buying Harrow stock or one of its competitors? The main competitors of Harrow include Legend Biotech (LEGN), Metsera (MTSR), Krystal Biotech (KRYS), Vaxcyte (PCVX), TG Therapeutics (TGTX), PTC Therapeutics (PTCT), Arrowhead Pharmaceuticals (ARWR), Arcellx (ACLX), Protagonist Therapeutics (PTGX), and Jyong Biotech (MENS). These companies are all part of the "pharmaceutical products" industry.

Harrow vs. Its Competitors

Legend Biotech (NASDAQ:LEGN) and Harrow (NASDAQ:HROW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Legend Biotech has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Harrow has a beta of 0.27, meaning that its stock price is 73% less volatile than the S&P 500.

70.9% of Legend Biotech shares are held by institutional investors. Comparatively, 72.8% of Harrow shares are held by institutional investors. 0.0% of Legend Biotech shares are held by insiders. Comparatively, 15.2% of Harrow shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Legend Biotech had 7 more articles in the media than Harrow. MarketBeat recorded 9 mentions for Legend Biotech and 2 mentions for Harrow. Legend Biotech's average media sentiment score of 0.08 beat Harrow's score of 0.00 indicating that Legend Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Legend Biotech
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Harrow
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Legend Biotech presently has a consensus price target of $66.56, suggesting a potential upside of 110.15%. Harrow has a consensus price target of $68.50, suggesting a potential upside of 75.46%. Given Legend Biotech's stronger consensus rating and higher possible upside, equities analysts clearly believe Legend Biotech is more favorable than Harrow.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Legend Biotech
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.73
Harrow
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

Harrow has a net margin of -4.49% compared to Legend Biotech's net margin of -40.83%. Harrow's return on equity of -2.18% beat Legend Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Legend Biotech-40.83% -32.00% -20.07%
Harrow -4.49%-2.18%-0.35%

Harrow has lower revenue, but higher earnings than Legend Biotech. Harrow is trading at a lower price-to-earnings ratio than Legend Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Legend Biotech$627.24M9.32-$177.03M-$0.88-35.99
Harrow$199.61M7.24-$17.48M-$0.25-156.16

Summary

Legend Biotech and Harrow tied by winning 8 of the 16 factors compared between the two stocks.

Get Harrow News Delivered to You Automatically

Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HROW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HROW vs. The Competition

MetricHarrowMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.44B$2.64B$6.18B$10.59B
Dividend YieldN/A57.75%5.72%4.86%
P/E Ratio-156.1623.9429.6728.46
Price / Sales7.24778.82579.41225.02
Price / Cash284.41165.1936.5560.64
Price / Book20.025.5712.076.53
Net Income-$17.48M$33.06M$3.32B$276.75M
7 Day Performance-2.42%2.10%0.64%0.93%
1 Month Performance-18.46%5.91%5.17%1.41%
1 Year Performance-26.40%-2.82%61.77%31.59%

Harrow Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HROW
Harrow
2.3927 of 5 stars
$39.04
+0.4%
$68.50
+75.5%
-28.0%$1.44B$199.61M-156.16180
LEGN
Legend Biotech
2.911 of 5 stars
$32.91
+3.0%
$66.56
+102.2%
-27.9%$5.90B$627.24M-37.402,609
MTSR
Metsera
N/A$52.95
-0.1%
$55.75
+5.3%
N/A$5.57BN/A0.0081
KRYS
Krystal Biotech
4.8285 of 5 stars
$195.96
+3.0%
$223.00
+13.8%
+7.9%$5.51B$290.52M39.83210
PCVX
Vaxcyte
2.4185 of 5 stars
$42.90
+1.2%
$106.25
+147.7%
-62.9%$5.50BN/A-10.44160Positive News
TGTX
TG Therapeutics
4.3332 of 5 stars
$35.12
+1.3%
$49.00
+39.5%
+44.8%$5.50B$329M94.92290News Coverage
Positive News
PTCT
PTC Therapeutics
3.2734 of 5 stars
$68.36
+3.7%
$69.00
+0.9%
+57.3%$5.24B$806.78M9.811,410
ARWR
Arrowhead Pharmaceuticals
3.7922 of 5 stars
$38.47
+4.5%
$43.14
+12.1%
+87.5%$5.09B$3.55M-30.05400Positive News
ACLX
Arcellx
2.4802 of 5 stars
$86.77
-0.3%
$113.08
+30.3%
-4.7%$4.82B$107.94M-25.3780
PTGX
Protagonist Therapeutics
1.6135 of 5 stars
$76.72
-1.0%
$74.00
-3.5%
+58.8%$4.82B$434.43M109.60120Positive News
MENS
Jyong Biotech
N/A$59.01
+0.0%
N/AN/A$4.49BN/A0.0031

Related Companies and Tools


This page (NASDAQ:HROW) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners